PharmaBoardroom

Egypt: Tackling Hep C

With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a…

Korean Healthcare and Pharma’s 10-Year Plan

The administration of President Moon Jae-in is moving to ensure the enduring success of South Korea’s healthcare and life sciences industries…

Narihiko Yoshii – President, Mitsubishi Tanabe Pharma Korea

Narihiko Yoshii, president of Mitsubishi Tanabe Pharma Korea unveils the value that they are bringing to Korean patients by utilising legislation…

Staffan Schüberg – CEO, Esteve, Spain

Staffan Schüberg, CEO of Esteve, highlights the restructure of the company as it moves towards its new age of being a truly innovative pharmaceutical…

Regulatory Reform: Brazil

A brief insight into upcoming regulatory reforms in Brazilian pharma. Prepared in association with Trench, Rossi e Watanabe one of Brazil’s most…

Patents and Trademarks: Brazil

An overview of the legal framework for patents and trademarks for pharmaceuticals in Brazil. Prepared in association with Trench, Rossi e…

Product Liability: Brazil

The ins and outs of product liability in Brazilian pharma. Prepared in association with Trench, Rossi e Watanabe one of Brazil’s most prestigious…

Traditional Medicines & OTC Products: Brazil

A guide to the state-of-play regarding traditional medicines and over-the-counter (OTC) products in Brazil. Prepared in association with Trench, Rossi…